40
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Association between midlife vascular risk factors and estimated brain amyloid deposition

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Importance

          Midlife vascular risk factors have been associated with late-life dementia; whether these risk factors directly contribute to brain amyloid deposition is less well understood.

          Objective

          To determine if midlife vascular risk factors are associated with late-life brain amyloid deposition, measured using florbetapir positron emission tomography (PET).

          Design, Setting, and Participants

          Prospective cohort study in 3 U.S. communities (Washington County, MD; Forsyth County, NC; and Jackson, MS). 346 participants without dementia in the Atherosclerosis Risk in Communities (ARIC)-PET Amyloid Imaging Study; evaluation of vascular risk factors and markers since 1987-1989, with florbetapir PET scans (2011-2013).

          Exposures

          Vascular risk factors at ARIC baseline (ages 45-64) were evaluated in multivariable models including age, sex, race, APOE genotype, and educational level.

          Outcome

          Standardized Uptake Value Ratios (SUVR) were calculated from PET scans; a mean global cortical SUVR was calculated. Elevated florbetapir (defined at SUVR>1.2) was the dependent variable.

          Results

          In 322 participants without dementia and with nonmissing midlife vascular risk factors at baseline (43% black, 58% female, mean age 52), SUVR (positive in 164 (50.9%) of participants) was measured >20 years later (median followup 23.5; IQR 23.0-24.3) when participants were 67-88 (mean 76 y). Elevated body mass index midlife (BMI) was associated with elevated SUVR (OR 2.06, 95% CI 1.16, 3.65). At baseline, 65 participants had no vascular risk factors, 123 had one, and 134 had two or more; a higher number of midlife risk factors was associated with elevated amyloid SUVR at followup, 30.8% (n=20), 50.4% (n=62), and 61.2% (n=82), respectively. In adjusted models, compared to 0 midlife vascular risk factors, the odds ratio for elevated SUVR associated with 1 vascular risk factor was 1.88 (95% CI 0.95-3.72) and was 2.88 (95% CI 1.46-5.69) for 2 or more vascular risk factors No significant race by risk factor interactions were found. Late-life vascular risk factors were not associated with late-life brain amyloid: (2 or more late-life vascular risk factors compared to 0: OR 1.66, 95% CI 0.75-3.69).

          Conclusions and Relevance

          An increasing number of midlife vascular risk factors was significantly associated with elevated amyloid SUVR; this association was not significant for late-life risk factors. These findings are consistent with a role of vascular disease in the development of Alzheimer’s Disease.

          Related collections

          Author and article information

          Journal
          7501160
          5346
          JAMA
          JAMA
          JAMA
          0098-7484
          1538-3598
          19 March 2018
          11 April 2017
          27 April 2018
          : 317
          : 14
          : 1443-1450
          Affiliations
          [1 ]Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD
          [2 ]Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
          [3 ]Department of Radiology, Section of High Resolution Brain PET Imaging, Johns Hopkins University School of Medicine, Baltimore, MD
          [4 ]Department of Radiology, University of Mississippi Medical Center, Jackson, MS
          [5 ]Hagerstown Imaging, Hagerstown, MD
          [6 ]Department of Neurology, Mayo Clinic, Rochester, MN
          [7 ]Department of Radiology, Wake Forest School of Medicine, Winston-Salem, NC
          [8 ]Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC
          [9 ]Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD
          [10 ]Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD
          [11 ]Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
          [12 ]Department of Medicine, University of Mississippi Medical Center, Jackson, MS
          Author notes
          Corresponding Author: Rebecca F. Gottesman, MD PhD; Phipps 446D; 600 North Wolfe Street; Baltimore, MD; Fax 410-614-9807; Phone 410-614-2381; rgottesm@ 123456jhmi.edu
          Article
          PMC5921896 PMC5921896 5921896 nihpa951989
          10.1001/jama.2017.3090
          5921896
          28399252
          67b26f95-1acb-4c1c-92f9-b8c57e8db05f
          History
          Categories
          Article

          dementia,amyloid,hypertension,epidemiology
          dementia, amyloid, hypertension, epidemiology

          Comments

          Comment on this article